The Premium Business Information Source™

  

 

Molecular Medicine SpA via Olgettina, 58, 20132 Milano Italy Tel: 39/2-21277-1 URL: http://www.molmed.it Primary Symbol & Exchange: MLM - Common Stock - Italian Stock Exchange Industry: Biotechnology +  SIC Industry Code: 8731 - Commercial Physical and Biological Research +  NAICS Industry Code: 541710 - Research and Development in the Physical, Engineering, and Life Sciences Thomson Financial Business Description: The Group's principal activities are discovery, R & D, and clinical validation of innovative therapies for the treatment of cancer. It has evolved into biotechnology drug-developing Company, with a primary focus on novel cancer therapies. Its approach to cancer is based on an integrated strategy that provides both drugs effectively targeting the growing tumour mass in the acute stage, and highly selective therapies to eliminate residual disease. Alacra Alerts:    Receive alerts on the latest reports on Molecular Medicine SpA Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.

Premium Content Results:

Sorry, no results found in this category    Sorry, no results found in this category

Search for more premium content on Molecular Medicine SpA

Copyright © 2009 Alacra, Inc., 100 Broadway, Suite 1100, New York, NY 10005. All rights reserved.
Reproduction in whole or in part in any form or medium without express written permission is prohibited.